5,10,15,20-Tetrakis (4-chlorophenyl) porphyrin

5,10,15,20-Tetrakis (4-chlorophenyl) porphyrin (Compound 5) is a photosensitizer. 5,10,15,20-Tetrakis (4-chlorophenyl) porphyrin shows no significant photodynamic cytotoxicity. 5,10,15,20-Tetrakis (4-chlorophenyl) porphyrin is mainly used for the optimization of photosensitizer structure in photodynamic therapy (PDT) for psoriasis[1].

Product Specifications

CAS Number

[22112-77-2]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Photosensitizer

Related Pathways

Apoptosis

Field of Research

Inflammation/Immunology

Purity

97.0

Smiles

ClC1=CC=C(/C2=C3C=CC(/C(C4=CC=C(Cl)C=C4)=C5C=C/C(N/5)=C(C6=CC=C(Cl)C=C6)/C(C=C/7)=NC7=C(C8=CC=C(Cl)C=C8)/C9=CC=C2N9)=N\3)C=C1

Molecular Formula

C44H26Cl4N4

Molecular Weight

752.52

Precautions

H302, H315, H319, H335

References & Citations

[1]Slomp AM, Barreira SMW, Carrenho LZB, Vandresen CC, Zattoni IF, Ló SMS, Dallagnol JCC, Ducatti DRB, Orsato A, Duarte MER, Noseda MD, Otuki MF, Gonçalves AG. Photodynamic effect of meso- (aryl) porphyrins and meso- (1-methyl-4-pyridinium) porphyrins on HaCaT keratinocytes. Bioorg Med Chem Lett. 2017 Jan 15;27 (2) :156-161.